Fundraising Fox株式会社Vetanic
1 known investors
Find your way into 株式会社Vetanic
Sign up to see every warm intro you have to 株式会社Vetanic
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社Vetanic team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vetanic develops regenerative medicine products and biologics for animals, starting with dogs, using its own animal iPS cell technology to produce donor-independent treatments such as canine mesenchymal stem cells (MSC). The company, based on joint research by Nihon University and Keio University, targets veterinarians and pet owners in Japan and is pursuing regulatory approval from the Ministry of Agriculture, Forestry and Fisheries.
Investors · 1
Frequently asked questions
- What does 株式会社Vetanic do?
- Vetanic develops regenerative medicine products and biologics for animals, starting with dogs, using its own animal iPS cell technology to produce donor-independent treatments such as canine mesenchymal stem cells (MSC). The company, based on joint research by Nihon University and Keio University, targets veterinarians and pet owners in Japan and is pursuing regulatory approval from the Ministry of Agriculture, Forestry and Fisheries.
- Who are 株式会社Vetanic's investors?
- 株式会社Vetanic's investors include Keio Innovation Initiative.